Antigen processing and presentation

Tissue Antigens

Volumn 47, Issue 6, 1996, Pages 464-471

  Brodsky, F M ^a   Lem, L ^a   Bresnahan, P A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antigen processing; Presentation

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; MEMBRANE ANTIGEN;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; HLA SYSTEM; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0029886062     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1996.tb02587.x     Document Type: Review

References (68)

1. Brodsky FM, Guagliardi LE. The cell biology of antigen processing and presentation. Annu Rev Immunol 1991: 9: 707-744.
2. Peters PJ, Neefjes JJ, Oorschot V, Ploegh HL, Geuze HJ. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 1991: 349: 669-676.
3. West MA, Lucocq JAM, Watts C. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature 1994: 369: 147-151.
4. Madden DR. The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol 1995: 12: 181-208.
5. Engelhard VH. Structure of peptides associated with class I and class II MHC molecules. Annu Rev Immunol 1994: 12: 181-208.
6. Barber LD, Gillece-Castro B, Percival L, Li X, Clayberger C, Parham P. Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes. Curr Biol 1995: 5: 179-990.
7. Trowsdale J, Hanson I, Mockridge I, Beck S, Townsend A, Kelly A. Sequences encoded in the class II region of the MHC related to the "ABC" superfamily of transporters. Nature 1990: 348: 741-744.
8. Monaco JJ, Cho S, Attaya M. Transport protein genes in the murine MHC: possible implications for antigen processing. Science 1990: 250: 1723-1726.
9. Shepherd JC, Schumacher TNM, Ashton-Rickardt PG et al. TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell 1993: 74: 577-584.
10. Kelly A, Powis SH, Glynne R, Radley E, Beck S, Trowsdale J. Second proteasome-related gene in the human MHC class II region. Nature 1991: 353: 667-668.
11. Martinez CK, Monaco JJ. Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene. Nature 1991: 353: 664-667.
12. Rock KL, Gramm C, Rothstein L et al. Inhibitors of the proteasome block the degradation of most cell proteins and generation of peptides presented on MHC class I molecules. Cell 1994: 78: 761-771.
13. Van Kaer L, Ashton-Rickardt PG, Eichelberger M et al. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1994: 1: 533-541.
14. Fehling HJ, Swat W, Laplace C et al. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 1994: 265: 1234-1237.
15. Kelly AP, Monaco JJ, Cho S, Trowsdale J. A new human HLA class II-related locus, DM. Nature 1991: 353: 571-573.
16. Morris P, Shaman J, Attaya M et al. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 1994: 368: 551-554.
17. Denzin LK, Cresswell P. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 1995: 82: 155-165.
18. Barber LD, Parham P. Peptide binding to major histocompatibility complex molecules. Annu Rev Cell Biol 1993: 9: 163-206.
19. Townsend A, Elliott T, Cerundolo V, Foster L, Barber B, Tse A. Assembly of MHC class I molecules analyzed in vitro. Cell 1990: 62: 285-295.
20. Hill A, Jugovic P, York I et al. Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995: 375: 411-413.
21. Grandea AG, Androlewicz MJ, Athwal RS, Geraghty DE, Spies T. Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science 1995: 270: 105-108.
22. Ljunggren H-G, Stam NJ, Öhlén C et al. Empty MHC class I molecules come out in the cold. Nature 1990: 346: 476-480.
23. Madrigal JA, Belich MP, Benjamin RJ et al. Molecular definition of a polymorphic antigen (LA45) of free HLA-A and HLA-B heavy chains found on the surfaces of activated B and T cells. J Exp Med 1991: 174: 1085-1095.
24. Peters J-M. Proteasomes: protein degradation machines of the cell. Biochem Sci 1994: 19: 377-382.
25. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell 1994: 79: 13-21.
26. Townsend A, Bastin J, Gould K et al. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med 1988: 168: 1211-1224.
27. Gaczynska M, Rock K, Goldberg A. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 1993: 365: 264-267.
28. Momberg F, Ortiz-Navarrete V, Neefjes J et al. Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation. Nature 1992: 360: 174-177.
29. Higgins CF. ABC transporters: from microorganisms to man. Annu Rev Cell Biol 1992: 8: 67-113.
30. Kelly A, Powis SH, Kerr L-A et al. Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature 1992: 355: 641-644.
31. Powis SJ, Deverson EV, Coadwell AC et al. Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule. Nature 1992: 357: 211-215.
32. van Endert PM, Riganelli D, Greco G et al. The peptide-binding motif for the human transporter associated with antigen processing. J Exp Med 1995: 182: 1883-1895.
33. Ortmann B, Androlewicz MJ, Cresswell P. MHC class I/β2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 1994: 368: 864-867.
34. Nössner E, Parham P. Species specific difference in chaperone interaction of human and mouse major histocompatibility complex class I molecules. J Exp Med 1995: 181: 327-337.
35. Williams DB, Watts TH. Molecular chaperones in antigen presentation. Curr Opin Immunol 1995: 7: 77-84.
36. Bresnahan PA, Barber LD, Parham P, Brodsky FM. Compartmentalization of peptide loading onto class I histocompatibility molecules in the endoplasmic reticulum. In preparation..
37. Hsu VW, Yuan LC, Nuchtern JG, Lippincott-Schwartz J, Hammerling GJ, Klausner RD. A recycling pathway between the endoplasmic reticulum and the Golgi apparatus for retention of unassembled MHC class I molecules. Nature 1991: 353: 441.
38. Raposo G, Santen HMv, Leijendekker R, Geuze HJ, Ploegh HL. Misfolded major histocompatibility complex class I molecules accumulate in an expanded ER-Golgi intermediate compartment. J Cell Biol 1995: 131: 1403-1419.
39. Ward CL, Omura S, Kopito RR. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 1995: 83: 121-127.
40. Kovacsovics-Bankowski M, Rock KL. A phagosome-to-cytosol pathway lor exogenous antigens presented on MHC class I molecules. Science 1995: 267: 243-246.
41. Reis e Sousa C, Germain RN. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged by phagocytosis. J Exp Med 1995: 182: 841-851.
42. Amigorena S, Drake JR, Webster P, Mellman I. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 1994: 369: 113-120.
43. Tulp A, Verwoerd D, Dobberstein B, Ploegh HL, Peiters J. Isolation and characterization of the intracellular MHC class II compartment. Nature 1994: 369: 120-126.
44. Calafat J, Nijenhuis M, Janssen H et al. Major histocompatibility complex class II molecules induce the formation of endocytic MIIC-like structures. J Cell Biol 1994: 126: 967-977.
45. Pieters J, Horstmann H, Bakke O, Griffiths G, Lipp J. Intracellular transport and localization of MHC class II molecules and associated invariant chain. J Cell Biol 1991: 115: 1213-1223.
46. Cresswell P. Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol 1994: 12: 259-294.
47. Roche P, Teletski C, Stang E, Bakke O, Long E. Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. Proc Natl Acad Sci U S A 1993: 90: 8581-8585.
48. Odorizzi C, Trowbridge I, Xue L, Hopkins C, Davis C, Collawn J. Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment. J Cell Biol 1994: 126: 317-30.
49. Guagliardi L, Koppelman B, Blum J, Marks M, Cresswell P, Brodsky F. Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment. Nature 1990: 343: 133-139.
50. Castellino F, Germain RN. Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. Immunity 1995: 2: 73-88.
51. Barnes KA, Mitchell RN. Detection of functional class II-associated antigen: role of a low density endosomal compartment in antigen processing. J Exp Med 1995: 181: 1715-1727.
52. McCoy K, Gainey D, Inman J, Stutzman R. Antigen presentation by B lymphoma cells. Requirements for processing of exogenous antigen internalized through transferrin receptors. J Immunol 1993: 151: 4583-94.
53. Sanderson F, Kleijmeer MJ, Kelly A et al. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science 1994: 266: 1566-1569.
54. Sloan V, Cameron P, Porter G et al. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 1995: 375: 802-806.
55. Sherman MA, Weber DA, Jensen PE. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 1995: 3: 197-205.
56. Lindstedt R, Liljedahl M, Peleraux A, Peterson P, Karlsson L. The MHC class II molecule H2-M is targeted to an endosomal compartment by a tyrosine-based targeting motif. Immunity 1995: 3: 561-572.
57. Marks MS, Roche PA, van Donselaar E, Woodruff L, Peters PJ, Bonifacino JS. A lysosomal targeting signal in the cytoplasmic tail of the β chain directs HLA-DM to MHC class II compartments. J Cell Biol 1995: 131: 351-369.
58. Pinet V, Vergelli M, Martin R, Bakke O, Long EO. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 1995: 375: 603-606.
59. Jensen PE. Regulation of antigen presentation by acidic pH. J Exp Med 1990: 171: 1770-1784.
60. Raposo G, Nijman H, Stoorvogel W, Leijendekker R, Harding C, Melief C, Geuze H. B Lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996: 183: 1161-1172.
61. Sturgill-Koszycki S, Schlesinger PH, Chakraborty PL et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton ATPase. Science 1994: 263: 678-681.
62. Hackstadt T, Scidmore MA, Rockey DD. Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc Natl Acad Sci USA 1995: 92: 4877-4881.
63. Pancholi P, Mirza A, Bhardwaj N, Steinman RM. Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages. Science 1993: 260: 984-986.
64. Reiner S, Locksley R. The regulation of immunity to Leishmania major. Annu Rev Immunol 1995: 13: 151-77.
65. Jaraquemada D, Marti M, Long EO. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells. J Exp Med 1990: 172: 947-954.
66. Malnati MS, Marti M, LaVaute T et al. Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells. Nature 1992: 357: 702-704.
67. Dice JF. Peptide sequences that target cytosolic proteins for lysosomal proteolysis. Trends Biochem Sci 1990: 15: 305-309.
68. Long EO. Intracellular traffic and antigen processing. Immunol Today 1989: 10: 232-234.